Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors

NCT01642342 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

102

Enrollment

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

OTHER: laboratory biomarker analysis
OTHER: pharmacological study
BIOLOGICAL: recombinant albumin fusion protein sEphB4-HSA

Sponsor

University of Southern California

Collaborators

[object Object]
[object Object]
[object Object]